铂-话题@MedSci

#铂#

382篇内容 | 6061人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1737706, encodeId=1e381e3770656, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Clin Cancer Res：局部进展期鼻咽癌患者顺铂两种不同给药方式治疗的疗效和安全性评估：随机对照临床研究, objectType=article, longId=213227, objectId=2d7321322eb9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d7321322eb9, replyNumber=0, likeNumber=79, createdTime=2021-10-18, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d7321322eb9, moduleTitle=Clin Cancer Res：局部进展期鼻咽癌患者顺铂两种不同给药方式治疗的疗效和安全性评估：随机对照临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d7321322eb9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737746, encodeId=2dbb1e37746a6, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=恩再适防治奥沙利铂相关神经毒性的临床观察, objectType=article, longId=220722, objectId=453a220e2245, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=453a220e2245, replyNumber=0, likeNumber=71, createdTime=2022-02-20, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=453a220e2245, moduleTitle=恩再适防治奥沙利铂相关神经毒性的临床观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=453a220e2245)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737693, encodeId=ef301e37693ec, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Eur Urol：铂治疗的局部晚期或转移性尿路上皮癌患者的Atezolizumab与化疗治疗比较 , objectType=article, longId=211015, objectId=27af21101554, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27af21101554, replyNumber=0, likeNumber=71, createdTime=2021-10-14, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27af21101554, moduleTitle=Eur Urol：铂治疗的局部晚期或转移性尿路上皮癌患者的Atezolizumab与化疗治疗比较 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27af21101554)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737682, encodeId=6c901e37682b8, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=武田呈报Mobocertinib治疗先前接受过含铂化疗的EGFR外显子20插入+ mNSCLC患者的阳性结果, objectType=article, longId=206667, objectId=b05220666ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b05220666ed0, replyNumber=0, likeNumber=97, createdTime=2021-12-09, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b05220666ed0, moduleTitle=武田呈报Mobocertinib治疗先前接受过含铂化疗的EGFR外显子20插入+ mNSCLC患者的阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b05220666ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737716, encodeId=c56b1e37716b0, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JAMA Netw Open：铂类化疗药物基础上加用硫代硫酸钠，患者的耳毒性风险是否会更低？, objectType=article, longId=215264, objectId=bc462152649e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc462152649e, replyNumber=0, likeNumber=60, createdTime=2022-01-19, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc462152649e, moduleTitle=JAMA Netw Open：铂类化疗药物基础上加用硫代硫酸钠，患者的耳毒性风险是否会更低？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc462152649e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737699, encodeId=a2da1e3769927, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JTO:信迪利单抗（Sintilimab）联合吉西他滨+铂类一线治疗局部进展或转移性鳞状非小细胞肺癌的疗效和安全性：随机双盲3期临床研究（ORIENT-12）。, objectType=article, longId=211989, objectId=b7c021198974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7c021198974, replyNumber=0, likeNumber=65, createdTime=2021-07-05, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7c021198974, moduleTitle=JTO:信迪利单抗（Sintilimab）联合吉西他滨+铂类一线治疗局部进展或转移性鳞状非小细胞肺癌的疗效和安全性：随机双盲3期临床研究（ORIENT-12）。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7c021198974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737747, encodeId=047d1e3774703, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Clin Cancer Res：碱基切除修复抑制剂TRC102联合培美曲塞-顺铂-放疗标准方案治疗晚期非鳞状非小细胞肺癌, objectType=article, longId=220916, objectId=e3f82209162c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3f82209162c, replyNumber=0, likeNumber=74, createdTime=2022-07-12, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3f82209162c, moduleTitle=Clin Cancer Res：碱基切除修复抑制剂TRC102联合培美曲塞-顺铂-放疗标准方案治疗晚期非鳞状非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3f82209162c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737674, encodeId=70581e37674b9, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle= J Clin Oncol：卡铂/依托泊苷方案+阿妥珠单抗作为广泛期小细胞肺癌一线治疗方案的延长随访预后结果（IMpower133试验）, objectType=article, longId=205905, objectId=050d20590572, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=050d20590572, replyNumber=0, likeNumber=117, createdTime=2021-10-22, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=050d20590572, moduleTitle= J Clin Oncol：卡铂/依托泊苷方案+阿妥珠单抗作为广泛期小细胞肺癌一线治疗方案的延长随访预后结果（IMpower133试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=050d20590572)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737741, encodeId=4f451e37741ff, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Ann Oncol：大型前瞻性GWAS鉴定预测奥沙利铂介导的周围感觉神经病变(PSN)的单核苷酸多态性(SNPs), objectType=article, longId=220257, objectId=925e22025e7a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=925e22025e7a, replyNumber=0, likeNumber=79, createdTime=2021-11-15, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=925e22025e7a, moduleTitle=Ann Oncol：大型前瞻性GWAS鉴定预测奥沙利铂介导的周围感觉神经病变(PSN)的单核苷酸多态性(SNPs), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=925e22025e7a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737688, encodeId=24891e3768897, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=EMBO Rep：铂激活Toll样受体4且有助于顺铂诱导的耳毒性 , objectType=article, longId=209755, objectId=a6ac209e553e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6ac209e553e, replyNumber=0, likeNumber=76, createdTime=2021-08-28, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6ac209e553e, moduleTitle=EMBO Rep：铂激活Toll样受体4且有助于顺铂诱导的耳毒性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6ac209e553e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737677, encodeId=42701e37677b5, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=铂敏感复发性卵巢癌维持治疗：如何选择？, objectType=article, longId=206059, objectId=48ca206059f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48ca206059f4, replyNumber=0, likeNumber=64, createdTime=2021-06-22, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48ca206059f4, moduleTitle=铂敏感复发性卵巢癌维持治疗：如何选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48ca206059f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737727, encodeId=088a1e37727eb, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Clin Oncol：3期| 纳武单抗 vs 吉西他滨或阿霉素用于铂耐药的卵巢癌的疗效和安全性, objectType=article, longId=216715, objectId=565a216e15f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=565a216e15f8, replyNumber=0, likeNumber=113, createdTime=2022-04-11, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=565a216e15f8, moduleTitle=J Clin Oncol：3期| 纳武单抗 vs 吉西他滨或阿霉素用于铂耐药的卵巢癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=565a216e15f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737719, encodeId=5c921e3771990, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=The Oncologist：转移性尿路上皮癌铂类为基础化疗进展后再挑战的疗效, objectType=article, longId=215461, objectId=9370215461b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9370215461b2, replyNumber=0, likeNumber=75, createdTime=2022-04-28, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9370215461b2, moduleTitle=The Oncologist：转移性尿路上皮癌铂类为基础化疗进展后再挑战的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9370215461b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737707, encodeId=1cc21e377075b, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Eur J Cancer：奥沙利铂/卡培他滨联合放疗（OxCapRT）对比紫杉醇/卡铂联合放疗（CarPacRT）新辅助治疗对可切除食管腺癌的疗效和安全性：NeoSCOPE长期随访结果, objectType=article, longId=213266, objectId=96fd2132664f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96fd2132664f, replyNumber=0, likeNumber=69, createdTime=2022-01-13, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96fd2132664f, moduleTitle=Eur J Cancer：奥沙利铂/卡培他滨联合放疗（OxCapRT）对比紫杉醇/卡铂联合放疗（CarPacRT）新辅助治疗对可切除食管腺癌的疗效和安全性：NeoSCOPE长期随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96fd2132664f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737676, encodeId=0f621e37676e5, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=BRCA1/2突变铂敏感型复发性卵巢癌：奥拉帕利较非铂化疗能有效改善PFS, objectType=article, longId=206058, objectId=87ad20605893, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87ad20605893, replyNumber=0, likeNumber=61, createdTime=2021-03-19, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87ad20605893, moduleTitle=BRCA1/2突变铂敏感型复发性卵巢癌：奥拉帕利较非铂化疗能有效改善PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87ad20605893)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737664, encodeId=149c1e3766443, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Nat Med：不适合顺铂治疗的高风险尿路上皮癌患者的新辅助PD-L1加CTLA-4阻断疗法, objectType=article, longId=202749, objectId=c7e3202e494d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7e3202e494d, replyNumber=0, likeNumber=54, createdTime=2021-01-12, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7e3202e494d, moduleTitle=Nat Med：不适合顺铂治疗的高风险尿路上皮癌患者的新辅助PD-L1加CTLA-4阻断疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7e3202e494d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737713, encodeId=2b201e37713a9, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Eur J Cancer：紫杉醇在氟嘧啶和铂类难治性食管鳞癌中的效果明显优于多西他赛！, objectType=article, longId=215144, objectId=fb9b21514490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb9b21514490, replyNumber=0, likeNumber=100, createdTime=2022-02-24, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb9b21514490, moduleTitle=Eur J Cancer：紫杉醇在氟嘧啶和铂类难治性食管鳞癌中的效果明显优于多西他赛！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb9b21514490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737732, encodeId=17c81e3773264, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Int J Cancer：多西他赛+卡铂 vs 表阿霉素+环磷酰胺续贯多西他赛新辅助化疗治疗早期三阴型乳腺癌的疗效对比：多中心随机对照研究(NeoCART), objectType=article, longId=218117, objectId=5c0921811e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c0921811e5f, replyNumber=0, likeNumber=70, createdTime=2022-06-16, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c0921811e5f, moduleTitle=Int J Cancer：多西他赛+卡铂 vs 表阿霉素+环磷酰胺续贯多西他赛新辅助化疗治疗早期三阴型乳腺癌的疗效对比：多中心随机对照研究(NeoCART), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c0921811e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737730, encodeId=fffa1e377306f, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Cancer：儿童铂化疗后的听力损失发病率调查, objectType=article, longId=217568, objectId=b0b921e568a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0b921e568a8, replyNumber=0, likeNumber=93, createdTime=2022-04-25, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0b921e568a8, moduleTitle=Cancer：儿童铂化疗后的听力损失发病率调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0b921e568a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737680, encodeId=fc821e37680dd, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Mol Neurobiol：Lmo4缺失增强了对顺铂诱导的耳蜗凋亡和听力损失的敏感性, objectType=article, longId=206328, objectId=8c43206328a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c43206328a0, replyNumber=0, likeNumber=85, createdTime=2021-12-31, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c43206328a0, moduleTitle=Mol Neurobiol：Lmo4缺失增强了对顺铂诱导的耳蜗凋亡和听力损失的敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c43206328a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

铂

2020-05-29

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Clin Cancer Res：局部进展期鼻咽癌患者顺铂两种不同给药方式治疗的疗效和安全性评估：随机对照临床研究

2021-10-18

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

恩再适防治奥沙利铂相关神经毒性的临床观察

2022-02-20

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Eur Urol：铂治疗的局部晚期或转移性尿路上皮癌患者的Atezolizumab与化疗治疗比较

2021-10-14

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

武田呈报Mobocertinib治疗先前接受过含铂化疗的EGFR外显子20插入+ mNSCLC患者的阳性结果

2021-12-09

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JAMA Netw Open：铂类化疗药物基础上加用硫代硫酸钠，患者的耳毒性风险是否会更低？

2022-01-19

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JTO:信迪利单抗（Sintilimab）联合吉西他滨+铂类一线治疗局部进展或转移性鳞状非小细胞肺癌的疗效和安全性：随机双盲3期临床研究（ORIENT-12）。

2021-07-05

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Clin Cancer Res：碱基切除修复抑制剂TRC102联合培美曲塞-顺铂-放疗标准方案治疗晚期非鳞状非小细胞肺癌

2022-07-12

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Clin Oncol：卡铂/依托泊苷方案+阿妥珠单抗作为广泛期小细胞肺癌一线治疗方案的延长随访预后结果（IMpower133试验）

2021-10-22

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Ann Oncol：大型前瞻性GWAS鉴定预测奥沙利铂介导的周围感觉神经病变(PSN)的单核苷酸多态性(SNPs)

2021-11-15

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

EMBO Rep：铂激活Toll样受体4且有助于顺铂诱导的耳毒性

2021-08-28

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

铂敏感复发性卵巢癌维持治疗：如何选择？

2021-06-22

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Clin Oncol：3期| 纳武单抗 vs 吉西他滨或阿霉素用于铂耐药的卵巢癌的疗效和安全性

2022-04-11

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

The Oncologist：转移性尿路上皮癌铂类为基础化疗进展后再挑战的疗效

2022-04-28

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Eur J Cancer：奥沙利铂/卡培他滨联合放疗（OxCapRT）对比紫杉醇/卡铂联合放疗（CarPacRT）新辅助治疗对可切除食管腺癌的疗效和安全性：NeoSCOPE长期随访结果

2022-01-13

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

BRCA1/2突变铂敏感型复发性卵巢癌：奥拉帕利较非铂化疗能有效改善PFS

2021-03-19

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Nat Med：不适合顺铂治疗的高风险尿路上皮癌患者的新辅助PD-L1加CTLA-4阻断疗法

2021-01-12

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Eur J Cancer：紫杉醇在氟嘧啶和铂类难治性食管鳞癌中的效果明显优于多西他赛！

2022-02-24

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Int J Cancer：多西他赛+卡铂 vs 表阿霉素+环磷酰胺续贯多西他赛新辅助化疗治疗早期三阴型乳腺癌的疗效对比：多中心随机对照研究(NeoCART)

2022-06-16

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Cancer：儿童铂化疗后的听力损失发病率调查

2022-04-25

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Mol Neurobiol：Lmo4缺失增强了对顺铂诱导的耳蜗凋亡和听力损失的敏感性

2021-12-31

科室
- - 订阅+
  - 更多科室
工具
服务